Neoadjuvant gemcitabine-based accelerated hyperfractionation chemoradiotherapy for patients with borderline resectable pancreatic adenocarcinoma.
暂无分享,去创建一个
Y. Takeda | H. Eguchi | Y. Doki | M. Mori | S. Marubashi | H. Nagano | K. Umeshita | Y. Yoshioka | Shogo Kobayashi | M. Tanemura | S. Nakamori | K. Konishi